Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
|
IN |
|
Aurora Cannabis Inc
TSX:ACB
|
CA |
|
Loblaw Companies Ltd
TSX:L
|
CA |
|
E
|
ESCO Technologies Inc
F:ET7
|
US |
Wall St Price Targets
LALPATHLAB Price Targets Summary
Dr. Lal PathLabs Ltd
According to Wall Street analysts, the average 1-year price target for LALPATHLAB is 1 715.31 INR with a low forecast of 1 191.8 INR and a high forecast of 2 175.6 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LALPATHLAB's stock price target?
Price Target
1 715.31
INR
According to Wall Street analysts, the average 1-year price target for LALPATHLAB is 1 715.31 INR with a low forecast of 1 191.8 INR and a high forecast of 2 175.6 INR.
What is the Revenue forecast for Dr. Lal PathLabs Ltd?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 6 years is 15%.
What is the Gross Profit forecast for Dr. Lal PathLabs Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Dr. Lal PathLabs Ltd?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 17%. The projected CAGR for the next 3 years is 15%.
What is the Pre-Tax Income forecast for Dr. Lal PathLabs Ltd?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 18%. The projected CAGR for the next 2 years is 18%.
What is the Net Income forecast for Dr. Lal PathLabs Ltd?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Net Income has been 19%. The projected CAGR for the next 3 years is 16%.
